Sept 10 (Reuters) - scPharmaceuticals Inc SCPH.O :
* . PRESENTS LATE-BREAKING FREEDOM-HF STUDY DATA AT HEART
FAILURE
SOCIETY OF AMERICA ANNUAL SCIENTIFIC MEETING 2021
* SCPHARMACEUTICALS - DATA SHOW STATISTICALLY SIGNIFICANT
REDUCTION IN BOTH HEART FAILURE-RELATED & OVERALL HEALTHCARE
COSTS FOR PATIENTS TREATED WITH FUROSCIX VERSUS HISTORICAL
COMPARATOR GROUP
* COMPANY ON TRACK TO RESUBMIT FUROSCIX NDA IN Q4 2021
Source text for Eikon: ID:nGNXgb62q
Further company coverage: SCPH.O
((Reuters.Briefs@thomsonreuters.com;))